Document is current
Any future updates will be listed below
-
Authors
Boschert, Alessa L. https://orcid.org/0000-0002-0004-8966
Gauger, Peter
Bach, Anja
Gerlach, Darius https://orcid.org/0000-0001-7044-6065
Johannes, Bernd
Jordan, Jens https://orcid.org/0000-0003-4518-0706
Li, Zhili
Elmenhorst, David https://orcid.org/0000-0001-6137-416X
Bauer, Andreas https://orcid.org/0000-0002-0117-3793
Marshall-Goebel, Karina https://orcid.org/0000-0002-5240-7625
Tank, Jens
Zange, Jochen
Rittweger, Jörn https://orcid.org/0000-0002-2223-8963
- License Information
-
More Information
Article History
Received: 2 February 2022
Accepted: 13 March 2023
First Online: 28 March 2023
Competing interests
: JJ has served as a consultant for Novartis, Boehringer-Ingelheim, and Novo-Nordisk and is co-founder of Eternygen GmbH (Modest relationship). All other authors have no conflict of interest.
